RVL Pharmaceuticals (RVLP) Q3 2022 Earnings

Nov 10Confirmed
Nov 2021
May 2022
Aug 2022
Q3 2022
-0.31
-0.23
-0.16
-0.08

Details

Expected EPS
-0.16
Actual EPS
-0.16
Surprise EPS
0
Surprise Percent
+0%

Description

⁨RVL Pharmaceuticals⁩ (⁦RVLP⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q3 2022⁩.

0 Comments

Share your thoughts